Login


TI Ref No : 515820055
Description : Contract Awarded For Dupilumab Exclusive Medicine Medication medication_suminist Of The Exclusive Medication Dupilumab, Dupixent®, In Its 200 Mg And 300 Mg Presentations, Injectable Solution, In Preloaded Pen, For The Health Centers Dependent On The Healt
Date : 2025-03-16
Deadline : 2025-05-25
Document Type : Contracts
View Details
Whats app